Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Colfax Corporation (CFX) stocks in Canada
Learn how to easily invest in Colfax Corporation stocks.
Colfax Corporation is a specialty industrial machinery business based in the US. Colfax Corporation stocks (CFX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $46.65 – a decrease of 2.15% over the previous week. Colfax Corporation employs 15,400 staff and has a trailing 12-month revenue of around $3.7 billion.
How to buy shares in Colfax Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CFX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Colfax Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Colfax Corporation?
- Has coronavirus impacted Colfax Corporation shares?
- Colfax Corporation shares summary
- Compare share dealing platforms
- Is Colfax Corporation stock a buy or sell?
- Colfax Corporation performance over time
- Are Colfax Corporation shares over-valued?
- Colfax Corporation's financials
- How volatile are Colfax Corporation shares?
- Does Colfax Corporation pay a dividend?
- Other common questions
How has Coronavirus impacted Colfax Corporation's stock price?
Since the stock market crash in March caused by coronavirus, Colfax Corporation's stock price has had significant positive movement.
Its last market close was $44.11, which is 11.81% up on its pre-crash value of $38.9 and 260.67% up on the lowest point reached during the March crash when the stocks fell as low as $12.23.
If you had bought $1,000 worth of Colfax Corporation stocks at the start of February 2020, those stocks would have been worth $416.40 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,224.49.
Colfax Corporation stock price (NYSE:CFX)Use our graph to track the performance of CFX stocks over time.
Colfax Corporation shares at a glance
|Latest market close||$44.11|
|52-week range||$36.73 - $54.67|
|50-day moving average||$47.32|
|200-day moving average||$46.55|
|Wall St. target price||$55.56|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.71|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Colfax Corporation price performance over time
|1 week (2022-01-08)||N/A|
|1 month (2021-12-17)||0.23%|
|3 months (2021-10-19)||-12.41%|
|6 months (2021-07-19)||3.21%|
|1 year (2021-01-19)||11.42%|
|2 years (2020-01-17)||15.87%|
|3 years (2019-01-18)||84.72%|
|5 years (2017-01-19)||18.13%|
Is Colfax Corporation under- or over-valued?
Valuing Colfax Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Colfax Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Colfax Corporation's P/E ratio
Colfax Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Colfax Corporation shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Colfax Corporation's PEG ratio
Colfax Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7288. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Colfax Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Colfax Corporation's EBITDA
Colfax Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $579.3 million.
The EBITDA is a measure of a Colfax Corporation's overall financial performance and is widely used to measure a its profitability.
Colfax Corporation financials
|Revenue TTM||$3.7 billion|
|Operating margin TTM||8.79%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||2.66%|
|Return on equity TTM||294.45%|
|Market capitalisation||$6.9 billion|
TTM: trailing 12 months
Colfax Corporation share dividends
We're not expecting Colfax Corporation to pay a dividend over the next 12 months.
Colfax Corporation share price volatility
Over the last 12 months, Colfax Corporation's shares have ranged in value from as little as $36.725 up to $54.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Colfax Corporation's is 2.1505. This would suggest that Colfax Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Colfax Corporation overview
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.
Stocks similar to Colfax Corporation
Frequently asked questions
Colfax Corporation in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes
This Isn't Your Father's Inflation, Value Over Growth Is Only Temporary
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.